Sipos Éva

1.

Herczeg, M., Demeter, F., Nagy, T., Rusznyák, Á., Hodek, J., Sipos, É., Lekli, I., Fenyvesi, F., Weber, J., Kéki, S., Borbás, A.: Block Synthesis and Step-Growth Polymerization of C-6-Sulfonatomethyl-Containing Sulfated Malto-Oligosaccharides and Their Biological Profiling.
Int. J. Mol. Sci. 25 (1), 1-29, (article identifier: 677), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Organic Chemistry (2023)

D1 Spectroscopy (2023)

D1 Inorganic Chemistry (2023)

Q1 Medicine (miscellaneous) (2023)

Q1 Physical and Theoretical Chemistry (2023)

Q1 Computer Science Applications (2023)

Q2 Molecular Biology (2023)

Q2 Catalysis (2023)

2.

Feró, O., Szabóné, V. D., Nagy, É., Karányi, Z., Sipos, É., Engelhardt, J., Török, N., Balogh, I., Vető, B., Liko, I., Fóthi, Á., Szabó, Z., Halmos, G., Vécsei, L., Arányi, T., Székvölgyi, L.: DNA methylome, R-loop and clinical exome profiling of patients with sporadic amyotrophic lateral sclerosis.
Sci Data. 11 (1), 1-12, (article identifier: 123), 2024.

doi DEA Scopus

Journal metrics:

D1 Computer Science Applications (2023)

D1 Education (2023)

D1 Information Systems (2023)

D1 Library and Information Sciences (2023)

D1 Statistics, Probability and Uncertainty (2023)

D1 Statistics and Probability (2023)

3.

Demeter, F., Peleskei, Z., Kútvölgyi, K., Rusznyák, Á., Fenyvesi, F., Kajtár, R., Sipos, É., Lekli, I., Molnár, P., Szöllősi, A. G., Lisztes, E., Tóth, I. B., Borbás, A., Herczeg, M.: Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides.
Biomolecules. 14 (9), 1-24, (article identifier: 1052), 2024.

doi DEA

Journal metrics:

Q1 Biochemistry (2023)

Q2 Molecular Biology (2023)

4.

Tran, T. B., Sipos, É., Bényei, A., Nagy, S., Lekli, I., Buglyó, P.: Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs.
Molecules. 29 (24), 1-14, (article identifier: 5967), 2024.

doi DEA

Journal metrics:

Q1 Analytical Chemistry (2023)

Q1 Chemistry (miscellaneous) (2023)

Q2 Drug Discovery (2023)

Q2 Medicine (miscellaneous) (2023)

Q3 Molecular Medicine (2023)

Q2 Organic Chemistry (2023)

Q1 Pharmaceutical Science (2023)

Q2 Physical and Theoretical Chemistry (2023)

5.

Fésüs, A., Baluku, P., Sipos, É., Somodi, S., Berczi-Kun, E., Lekli, I., Bácskay, I., Benkő, R., Vaskó, A.: The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): a before-after study.
Front. Pharm. 15, 1-12, 2024.

doi DEA

Journal metrics:

Q1 Pharmacology (2023)

Q1 Pharmacology (medical) (2023)

6.

Fésüs, A., Ábrahám, A., Sipos, É., Szőke, K., Bak, I., Kiss-Szikszai, A., Lekli, I.: Evaluation of the antioxidant effect of kd15 and kd36 newly synthetized molecules.
In: FAMÉ 2023 Mátraháza 7-9 June 2023 : Programme Oral and Poster Abstract / org. Hungarian Society For Experimental And Clinical Pharmacology, Hungarian Physiological Society, Hungarian Society For Microcirculation And Vascular Biology, HUPHAR, [S.l.], 223, 2023.

DEA

7.

Szabó, Z., Dezső, B., Molnár-Fodor, K., Szegedi, K., Flaskó, T., Szabó, E., Oláh, G., Sipos, É., Dobos, N., Gardi, J., Schally, A. V., Halmos, G.: Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
Molecules. 26 (5), 1-14, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

8.

Molnár-Fodor, K., Sipos, É., Dobos, N., Nagy, J., Steiber, Z., Méhes, G., Dull, K., Székvölgyi, L., Schally, A. V., Halmos, G.: Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
Life (Basel). 10 (12), 1-15, 2020.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Ecology, Evolution, Behavior and Systematics

Q1 Paleontology

Q2 Space and Planetary Science

9.

Molnár-Fodor, K., Dobos, N., Schally, A. V., Steiber, Z., Oláh, G., Sipos, É., Székvölgyi, L., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Oncotarget. 11 (2), 175-187, 2020.

doi DEA

Journal metrics:

Q2 Oncology

10.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: Corrigendum: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 29 (1), 157-157, 2019.

doi DEA

11.

Sipos, É., Dobos, N., Rózsa, D., Molnár-Fodor, K., Oláh, G., Szabó, Z., Székvölgyi, L., Schally, A. V., Halmos, G.: Characterization of Luteinizing hormone-releasing hormone (LH-RH-I) receptor type I as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.
OncoTargets Ther. 11, 933-941, 2018.

doi DEA

Journal metrics:

Q2 Oncology

Q2 Pharmacology (medical)

12.

Oláh, G., Dobos, N., Vámosi, G., Szabó, Z., Sipos, É., Molnár-Fodor, K., Harda, K. M., Schally, A. V., Halmos, G.: Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Eur. J. Pharm. Sci. 123, 371-376, 2018.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science

13.

Sipos, É., Dull, K., Treszl, A., Steiber, Z., Méhes, G., Dobos, N., Molnár-Fodor, K., Oláh, G., Székvölgyi, L., Schally, A. V., Halmos, G.: Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Oncol. Rep. 37, 1927-1934, 2017.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Medicine (miscellaneous)

Q2 Oncology

14.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 27, 1063-1073, 2017.

doi DEA

Journal metrics:

D1 Genetics

D1 Genetics (clinical)

15.

Szabó, I., Bősze, S., Orbán, E., Sipos, É., Halmos, G., Kovács, M., Mező, G.: Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
J. Pept. Sci. 21 (5), 426-435, 2015.

doi DEA

Journal metrics:

Q3 Biochemistry

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Biology

Q3 Molecular Medicine

Q2 Organic Chemistry

Q2 Pharmacology

Q3 Structural Biology

16.

Steiber, Z., Sipos, É., Dull, K., Halmos, G., Méhes, G., Treszl, A.: Aneuploidy of chromosome 3 and 4 in human uveal melanomas detected by fluorescence in situ hybridization.
Invest. Ophthalmol. Vis. Sci. 55, 6444, 2014.

DEA

17.

Hegedűs, R., Manea, M., Orbán, E., Szabó, I., Kiss, É., Sipos, É., Halmos, G., Mező, G.: Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
Eur. J. Med. Chem. 56, 155-165, 2012.

doi DEA

Journal metrics:

Q1 Drug Discovery

Q1 Medicine (miscellaneous)

Q1 Organic Chemistry

Q1 Pharmacology

Publication list